ANTICORPS À DOUBLE CIBLE, CIBLANT LE VEGFR-2 ET LE DLL4 ET COMPOSITION PHARMACEUTIQUE LE CONTENANT

• 收藏
• 分享

专利权人:

Pharmabcine Inc.

发明人:

申请号：

EP13857338.1

公开号：

EP2924052A1

申请日:

2013.11.20

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/